Flavio G. Rocha, MD, FACS, FSSO, Oregon Health & Science University

Articles

The Evolving Treatment Landscape of Biliary Tract Cancers

March 22nd 2023

Closing out their discussion on biliary tract cancers, expert panelists share key takeaways and excitement for the evolving treatment paradigm.

Novel Targeted Therapies Under Investigation in Biliary Tract Cancers

March 22nd 2023

Comprehensive insight on novel targeted agents under investigation in the setting of biliary tract cancers.

Biliary Tract Cancers: Combination Strategies With Immune Checkpoint Inhibitors

March 15th 2023

An overview on novel treatment strategies in biliary tract cancers combining immune checkpoint inhibitors with various targeted agents.

TOPAZ-1: Chemotherapy + Durvalumab in Biliary Tract Cancers

March 15th 2023

Centering discussion on the TOPAZ-1 trial of chemotherapy in combination with durvalumab, panelists consider how this regimen has impacted clinical practice.

Standard of Care Systemic Therapies for Biliary Tract Cancers

March 8th 2023

Key opinion leaders in the field of biliary tract cancers highlight mainstay systemic therapy regimens within the treatment paradigm.

Role for Liver Transplant in Biliary Tract Cancers

March 8th 2023

A brief discussion on the continued role of liver transplant in biliary tract cancers and when it is appropriate to consider a patient for this procedure.

Liver-Directed Treatment Strategies in Biliary Tract Cancers

March 1st 2023

A comprehensive review of liver-directed therapies available to aid in the management of biliary tract cancers.

Biliary Tract Cancers: Surgical and Perioperative Treatment Strategies

March 1st 2023

Moving on to identify specific treatment modalities, panelists discuss the surgical and perioperative strategies used to manage biliary tract cancers.

Advent of Molecular Testing in Biliary Tract Cancers

February 22nd 2023

Key opinion leaders review the advent of molecular testing in biliary tract cancers and consider its impact on informing treatment decisionmaking.

Optimizing the Staging of Biliary Tract Cancers

February 22nd 2023

Focused conversation on the optimal workup and staging of biliary tract cancers within the current paradigm.

Clinical Scenario: Diagnostic Strategies to Identify Biliary Tract Cancers

February 15th 2023

Centering focus on a patient scenario, panelists break down mainstay diagnostic strategies used to identify biliary tract cancers.

Overview on Biliary Tract Cancers and Their Rising Incidence

February 15th 2023

Expert panelists open their discussion on biliary tract cancers by identifying various subsets and noting the growing incidence of these diseases.

Advanced Biliary Tract Cancers: Novel Biomarker Strategies

November 9th 2022

Closing out their discussion on the management of biliary tract cancers, experts share excitement for future evolutions in the treatment landscape.

Novel Agents Being Explored in Advanced Biliary Tract Cancers

November 9th 2022

Expert panelists provide comprehensive insight on novel targeted agents being investigated in advanced biliary tract cancers.

Sequencing Therapy in Patients With Advanced Biliary Tract Cancers

November 2nd 2022

In the context of advanced biliary tract cancers, panelists reflect on the optimal sequencing of agents throughout multiple lines of therapy.

Advanced Biliary Tract Cancers: Managing Immunotherapy-Related Adverse Events

November 2nd 2022

Expert perspectives on the toxicity profile of immunotherapy agents and how they can be managed in patients being treated for advanced biliary tract cancers.

Advanced BTC: Informing Use of IO Therapy in Specific Patient Populations

October 26th 2022

Shared insight on efforts to identify patient subgroups that may benefit more from immunotherapy in the setting of advanced biliary tract cancers.

TOPAZ-1: Durvalumab + Doublet Chemotherapy in Advanced Biliary Tract Cancers

October 26th 2022

Centering their conversation on the TOPAZ-1 clinical trial, expert panelists review the use of IO + chemotherapy in advanced biliary tract cancers.

Advanced Biliary Tract Cancers: First- and Second-Line Chemotherapy

October 19th 2022

Focused discussion on chemotherapy treatment options commonplace in patients with advanced or metastatic biliary tract cancers.

An Overview of Systemic Therapy for Advanced Biliary Tract Cancers

October 19th 2022

Shifting their focus to the advanced disease setting, panelists provide a comprehensive overview on systemic treatment modalities used in biliary tract cancers.